
Development, manufacturing, and commercialization of plasma-derived biomedicines. Focus on public health and French health sovereignty.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
Biogaran
B
Production of generic medicines and health products, primarily manufactured in France and Europe.
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Pharma & Beauty Group
B
Development and production of formulas for the health and beauty sectors, including advanced manufacturing facilities in France.
Initiatives identified among leaders
Réduction des déchets et des émissions de CO2
“Takeda réduit ses déchets et ses émissions de CO2” - TakedaDéveloppement de produits cosmétiques respectueux de la peau et de l'environnement
“Pharma & Beauty Group développe des produits cosmé...” - Pharma & Beauty GroupDéveloppement de produits respectueux de l'environnement
“Pharma & Beauty Group développe des produits respe...” - Pharma & Beauty Group69% of similar organizations communicate on CSR issues
+4062 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports